These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2113676)

  • 1. Congenital toxoplasmosis: to screen or not to screen?
    Joss AW; Chatterton JM; Ho-Yen DO
    Public Health; 1990 Jan; 104(1):9-20. PubMed ID: 2113676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of preventive programmes against congenital toxoplasmosis.
    Stray-Pedersen B; Jenum P
    Scand J Infect Dis Suppl; 1992; 84():86-96. PubMed ID: 1290083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-benefit analysis of screening for toxoplasmosis during pregnancy.
    Lappalainen M; Sintonen H; Koskiniemi M; Hedman K; Hiilesmaa V; Ammälä P; Teramo K; Koskela P
    Scand J Infect Dis; 1995; 27(3):265-72. PubMed ID: 8539552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost-benefit analysis of screening for congenital toxoplasmosis].
    Sagmeister M; Gessner U; Kind C; Horisberger B
    Schweiz Med Wochenschr Suppl; 1995; 65():103S-112S. PubMed ID: 7716447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of prevention strategies for congenital toxoplasmosis: a critical review of medico-economic studies].
    Binquet C; Wallon M; Quantin C; Gadreau M; Peyron F
    Rev Epidemiol Sante Publique; 2002 Oct; 50(5):475-87. PubMed ID: 12471340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model.
    Stillwaggon E; Carrier CS; Sautter M; McLeod R
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1333. PubMed ID: 21980546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-saving.
    Prusa AR; Kasper DC; Sawers L; Walter E; Hayde M; Stillwaggon E
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005648. PubMed ID: 28692640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital toxoplasmosis: prevention, screening and treatment.
    Holliman RE
    J Hosp Infect; 1995 Jun; 30 Suppl():179-90. PubMed ID: 7560949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant women.
    Logar J; Petrovec M; Novak-Antolic Z; Premru-Srsen T; Cizman M; Arnez M; Kraut A
    Scand J Infect Dis; 2002; 34(3):201-4. PubMed ID: 12030394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening programme for congenital toxoplasmosis in France.
    Thulliez P
    Scand J Infect Dis Suppl; 1992; 84():43-5. PubMed ID: 1290073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of congenital toxoplasmosis in Norway.
    Stray-Pedersen B
    Arch Pediatr; 2003 Feb; 10 Suppl 1():23-4. PubMed ID: 12802962
    [No Abstract]   [Full Text] [Related]  

  • 12. What can be done to prevent congenital toxoplasmosis?
    Wilson CB; Remington JS
    Am J Obstet Gynecol; 1980 Oct; 138(4):357-63. PubMed ID: 6775534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for toxoplasmosis.
    Joss AW; Ho-Yen DO
    Public Health; 1990 Nov; 104(6):501-2. PubMed ID: 2125738
    [No Abstract]   [Full Text] [Related]  

  • 14. The evaluation of new services: possibilities for preventing congenital toxoplasmosis.
    Henderson JB; Beattie CP; Hale EG; Wright T
    Int J Epidemiol; 1984 Mar; 13(1):65-72. PubMed ID: 6421760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current situation regarding toxoplasmosis in Finland.
    Lappalainen M
    Arch Pediatr; 2003 Feb; 10 Suppl 1():19. PubMed ID: 12802959
    [No Abstract]   [Full Text] [Related]  

  • 16. Prenatal screening for toxoplasmosis.
    Bader TJ; Macones GA; Asch DA
    Obstet Gynecol; 1997 Sep; 90(3):457-64. PubMed ID: 9277662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis.
    Binquet C; Lejeune C; Seror V; Peyron F; Bertaux AC; Scemama O; Quantin C; Béjean S; Stillwaggon E; Wallon M
    PLoS One; 2019; 14(9):e0221709. PubMed ID: 31532766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choices in preventive strategies: experience with the prevention of congenital toxoplasmosis in The Netherlands.
    Conyn-van Spaedonck MA; van Knapen F
    Scand J Infect Dis Suppl; 1992; 84():51-8. PubMed ID: 1290075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital toxoplasmosis: prevention or palliation?
    Frenkel JK
    Am J Obstet Gynecol; 1981 Oct; 141(4):359-61. PubMed ID: 7282820
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for toxoplasmosis during pregnancy: the situation in Belgium.
    Naessens A
    Arch Pediatr; 2003 Feb; 10 Suppl 1():18. PubMed ID: 12802958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.